| Item Type | Name |
|
Concept
|
Leukemia
|
|
Concept
|
Leukemia, Lymphoid
|
|
Concept
|
Leukemia, Lymphocytic, Chronic, B-Cell
|
|
Concept
|
Leukemia, Myeloid
|
|
Concept
|
Leukemia, Myelomonocytic, Acute
|
|
Concept
|
Leukemia, Myeloid, Acute
|
|
Concept
|
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
|
|
Concept
|
Leukemia, Promyelocytic, Acute
|
|
Concept
|
Leukemia-Lymphoma, Adult T-Cell
|
|
Concept
|
Leukemia, Myeloid, Chronic-Phase
|
|
Concept
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma
|
|
Concept
|
Myeloid-Lymphoid Leukemia Protein
|
|
Concept
|
Leukemia, Monocytic, Acute
|
|
Concept
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
|
|
Academic Article
|
Analysis of the t(6;11)(q27;q23) in leukemia shows a consistent breakpoint in AF6 in three patients and in the ML-2 cell line.
|
|
Academic Article
|
Therapy-related myeloid leukemia.
|
|
Academic Article
|
Bronchiolitis obliterans organizing pneumonia as a complication of allogeneic bone marrow transplantation.
|
|
Academic Article
|
Distribution of 11q23 breakpoints within the MLL breakpoint cluster region in de novo acute leukemia and in treatment-related acute myeloid leukemia: correlation with scaffold attachment regions and topoisomerase II consensus binding sites.
|
|
Academic Article
|
Developmental analysis and subcellular localization of the murine homologue of ELL.
|
|
Academic Article
|
Chromatin-related properties of CBP fused to MLL generate a myelodysplastic-like syndrome that evolves into myeloid leukemia.
|
|
Academic Article
|
Retrovirus-mediated gene transfer of MLL-ELL transforms primary myeloid progenitors and causes acute myeloid leukemias in mice.
|
|
Academic Article
|
ELL and EAF1 are Cajal body components that are disrupted in MLL-ELL leukemia.
|
|
Academic Article
|
ELL-associated factor 2 (EAF2), a functional homolog of EAF1 with alternative ELL binding properties.
|
|
Academic Article
|
The elongation domain of ELL is dispensable but its ELL-associated factor 1 interaction domain is essential for MLL-ELL-induced leukemogenesis.
|
|
Academic Article
|
The elongation factor ELL (eleven-nineteen lysine-rich leukemia) is a selective coregulator for steroid receptor functions.
|
|
Academic Article
|
Methylation-independent silencing of the tumor suppressor INK4b (p15) by CBFbeta-SMMHC in acute myelogenous leukemia with inv(16).
|
|
Academic Article
|
Successful autologous stem cell collection in patients with chronic myeloid leukemia in complete cytogenetic response, with quantitative measurement of BCR-ABL expression in blood, marrow, and apheresis products.
|
|
Academic Article
|
Loss of MLL PHD finger 3 is necessary for MLL-ENL-induced hematopoietic stem cell immortalization.
|
|
Academic Article
|
Distinct microRNA expression profiles in acute myeloid leukemia with common translocations.
|
|
Academic Article
|
High dose cytarabine and mitoxantrone: an effective induction regimen for high-risk acute myeloid leukemia (AML).
|
|
Academic Article
|
Gene mutations, epigenetic dysregulation, and personalized therapy in myeloid neoplasia: are we there yet?
|
|
Academic Article
|
Cloning of ELL, a gene that fuses to MLL in a t(11;19)(q23;p13.1) in acute myeloid leukemia.
|
|
Academic Article
|
Rearrangements of the MLL gene in therapy-related acute myeloid leukemia in patients previously treated with agents targeting DNA-topoisomerase II.
|
|
Academic Article
|
Heterogeneity of breakpoints of 11q23 rearrangements in hematologic malignancies identified with fluorescence in situ hybridization.
|
|
Academic Article
|
DNA rearrangements and altered transcripts of the MLL gene in a human T-ALL cell line Karpas 45 with a t(X;11) (q13;q23) translocation.
|
|
Academic Article
|
A t(11;12) 11q23 leukemic breakpoint that disrupts the MLL gene.
|
|
Academic Article
|
The human MLL gene: nucleotide sequence, homology to the Drosophila trx zinc-finger domain, and alternative splicing.
|
|
Academic Article
|
Detection of MLL gene rearrangements in adult acute lymphoblastic leukemia. A Cancer and Leukemia Group B study.
|
|
Academic Article
|
Molecular analysis of the T-cell acute lymphoblastic leukemia-associated t(1;7)(p34;q34) that fuses LCK and TCRB.
|
|
Academic Article
|
Abnormalities of chromosome band 11q23 and the MLL gene in pediatric myelomonocytic and monoblastic leukemias. Identification of the t(9;11) as an indicator of long survival.
|
|
Academic Article
|
Do terminal deletions of 11q23 exist? Identification of undetected translocations with fluorescence in situ hybridization.
|
|
Academic Article
|
Consistent deregulation of gene expression between human and murine MLL rearrangement leukemias.
|
|
Academic Article
|
Aberrant overexpression and function of the miR-17-92 cluster in MLL-rearranged acute leukemia.
|
|
Academic Article
|
Detection of 11q23/MLL rearrangements in infant leukemias with fluorescence in situ hybridization and molecular analysis.
|
|
Academic Article
|
Cloning of cDNAs of the MLL gene that detect DNA rearrangements and altered RNA transcripts in human leukemic cells with 11q23 translocations.
|
|
Academic Article
|
EAF1, a novel ELL-associated factor that is delocalized by expression of the MLL-ELL fusion protein.
|
|
Academic Article
|
Fludarabine, melphalan, and alemtuzumab conditioning in adults with standard-risk advanced acute myeloid leukemia and myelodysplastic syndrome.
|
|
Academic Article
|
MLL fusion proteins preferentially regulate a subset of wild-type MLL target genes in the leukemic genome.
|
|
Academic Article
|
Rearrangement of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 11q23 chromosomal translocations.
|
|
Academic Article
|
A novel clofarabine bridge strategy facilitates allogeneic transplantation in patients with relapsed/refractory leukemia and high-risk myelodysplastic syndromes.
|
|
Academic Article
|
Regulation of MEIS1 by distal enhancer elements in acute leukemia.
|
|
Academic Article
|
Ibrutinib for patients with relapsed or refractory chronic lymphocytic leukaemia with 17p deletion (RESONATE-17): a phase 2, open-label, multicentre study.
|
|
Academic Article
|
Instructive Role of MLL-Fusion Proteins Revealed by a Model of t(4;11) Pro-B Acute Lymphoblastic Leukemia.
|
|
Academic Article
|
Efficacy of single-agent decitabine in relapsed and refractory acute myeloid leukemia.
|
|
Academic Article
|
Paradoxical Effects of MLL Paralogs in MLL-Rearranged Leukemia.
|
|
Academic Article
|
The full transforming capacity of MLL-Af4 is interlinked with lymphoid lineage commitment.
|
|
Academic Article
|
Treatment of Acute Promyelocytic Leukemia in Adults.
|
|
Academic Article
|
Quercetin Therapy for Selected Patients with PIM1 Kinase-Positive Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Pilot Study.
|
|
Academic Article
|
Clonal evolution underlying leukemia progression and Richter transformation in patients with ibrutinib-relapsed CLL.
|
|
Academic Article
|
A phase I study of selinexor in combination with high-dose cytarabine and mitoxantrone for remission induction in patients with acute myeloid leukemia.
|
|
Academic Article
|
Lenalidomide consolidation benefits patients with CLL receiving chemoimmunotherapy: results for CALGB 10404 (Alliance).
|
|
Academic Article
|
Safety and preliminary efficacy of venetoclax with decitabine or azacitidine in elderly patients with previously untreated acute myeloid leukaemia: a non-randomised, open-label, phase 1b study.
|
|
Academic Article
|
Entospletinib monotherapy in patients with relapsed or refractory chronic lymphocytic leukemia previously treated with B-cell receptor inhibitors: results of a phase 2 study.
|
|
Academic Article
|
A phase 1 study of azacitidine with high-dose cytarabine and mitoxantrone in high-risk acute myeloid leukemia.
|
|
Academic Article
|
Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia.
|
|
Academic Article
|
Venetoclax with azacitidine or decitabine in patients with newly diagnosed acute myeloid leukemia: Long term follow-up from a phase 1b study.
|
|
Academic Article
|
Measurable Residual Disease Response and Prognosis in Treatment-Naïve Acute Myeloid Leukemia With Venetoclax and Azacitidine.
|
|
Academic Article
|
Impact of FLT3 Mutation on Outcomes after Venetoclax and Azacitidine for Patients with Treatment-Naïve Acute Myeloid Leukemia.
|
|
Academic Article
|
Efficacy and tolerability of a modified pediatric-inspired intensive regimen for acute lymphoblastic leukemia in older adults.
|
|
Academic Article
|
Epigenetic regulator genes direct lineage switching in MLL/AF4 leukemia.
|
|
Academic Article
|
Clinical and molecular response of acute myeloid leukemia harboring non-canonical FLT3 N676K driver mutations to contemporary FLT3 inhibitors.
|
|
Academic Article
|
The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemia.
|
|
Academic Article
|
Socioeconomic determinants of the biology and outcomes of acute lymphoblastic leukemia in adults.
|
|
Academic Article
|
Long-term follow-up of VIALE-A: Venetoclax and azacitidine in chemotherapy-ineligible untreated acute myeloid leukemia.
|
|
Academic Article
|
Menin Inhibition With Revumenib for KMT2A-Rearranged Relapsed or Refractory Acute Leukemia (AUGMENT-101).
|